From Liver Injury to Hepatobiliary Cancer: Mechanisms, Metabolic Inflammation, and Clinical Evolution in the Post-DAA Era

Webinar

Time

March 24, 2026

14:00 (CET, GMT+1)
14:00 (Berlin, GMT+1)
14:00 (Rome, GMT+1)
21:00 (Beijing, GMT+8)
08:00 (New York, GMT−5)
07:00 (Chicago, GMT−6)

Download the webinar poster

Join the Webinar

Register link:
https://oaemesas.feishu.cn/share/base/form/shrcnhpxyRkhfgsA2cPcQZtqaSe

Call for papers! All high quality papers submitted to this webinar symposium will enjoy large discounts!
Sign up deadline: March 10, 2026
Contact: [email protected]
Submission deadline: March 31, 2026
Online submission: https://www.oaecenter.com/login?JournalId=hr

Chair

Giuliano Ramadori, MD

Professor of medicine, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany;
Executive Chief Editor of Hepatoma Research.

Speaker(s)

Silvia Gaia, MD

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy

Topic: Has the clinical profile of patients with hepatocellular carcinoma evolved in the post–HCV eradication era following the introduction of direct-acting antiviral (DAA) therapy?

Gian Paolo Caviglia, PhD

University of Turin, Turin, Italy

Topic: HCC after DAA treatment

Marina Serra, PhD

University of Cagliari, Cagliari, Italy

Topic: Experimental Models of HCC

Diego F Calvisi, MD, PhD

University of Regensburg, Regensburg, Germany

Topic: Mouse Models of Cholangiocarcinoma

Programme

Time (CET)	Sessions	Speakers	Topics
14:00-14:15	Opening Keynote	Prof. Giuliano Ramadori	What makes the Liver Cancer Development Process so Special?
14:15-14:35	Clinical Evolution I	Dr. Silvia Gaia	Has the clinical profile of patients with hepatocellular carcinoma evolved in the post-HCV eradication era following the introduction of direct-acting antiviral (DAA) therapy?
14:35-14:55	Clinical Evolution II	Dr. Gian Paolo Caviglia	HCC after DAA treatment
14:55-15:25	Experimental & Mechanistic Insights	Dr. Marina Serra	Experimental Models of HCC
15:25-15:55	Expanding the Spectrum	Prof. Diego F. Calvisi	Mouse Models of Cholangiocarcinoma
15:55-16:05	Discussion	All speakers	How do liver injury and regeneration intersect with metabolic inflammation to shape hepatobiliary cancer risk in the post-viral era?
16:05-16:10	Summary	Prof. Giuliano Ramadori	/